ENHANCED RESISTANCE TO STREPTOCOCCAL INFECTION INDUCED IN MICE BY CELL WALL MUCOPEPTIDE

Por Rotta, Jiri, Prendergast, Thomas J., Karakawa, Walter W., Harmon, Charles K., Krause, Richard M.
Publicado em 1965

Soluble KIT correlates with clinical outcome in patients with metastatic breast cancer treated with sunitinib

Por Keyvanjah Kiana, DePrimo Samuel E, Harmon Charles S, Huang Xin, Kern Kenneth A, Carley William
Publicado em 2012-08-01

Soluble KIT correlates with clinical outcome in patients with metastatic breast cancer treated with sunitinib

Por Keyvanjah, Kiana, DePrimo, Samuel E, Harmon, Charles S, Huang, Xin, Kern, Kenneth A, Carley, William
Publicado em 2012

Tumor-Associated Macrophages Are a Useful Biomarker to Predict Recurrence After Surgical Resection of Non-Functional Pancreatic Neuroendocrine Tumors

Por Wei, Iris H., Harmon, Charles M., Arcerito, Massimo, Cheng, Debbie F., Minter, Rebecca M., Simeone, Diane M.
Publicado no Ann Surg (2014)

Circulating Levels of Soluble KIT Serve as a Biomarker for Clinical Outcome in Gastrointestinal Stromal Tumor Patients Receiving Sunitinib following Imatinib Failure

Por DePrimo, Samuel E., Huang, Xin, Blackstein, Martin E., Garrett, Christopher R., Harmon, Charles S., Schöffski, Patrick, Shah, Manisha H., Verweij, Jaap, Baum, Charles M., Demetri, George D.
Publicado em 2009

Mechanism-related circulating proteins as biomarkers for clinical outcome in patients with unresectable hepatocellular carcinoma receiving sunitinib

Por Harmon, Charles S, DePrimo, Samuel E, Raymond, Eric, Cheng, Ann-Lii, Boucher, Eveline, Douillard, Jean-Yves, Lim, Ho Y, Kim, Jun S, Lechuga, Maria José, Lanzalone, Silvana, Lin, Xun, Faivre, Sandrine
Publicado em 2011

Circulating proteins as potential biomarkers of sunitinib and interferon-α efficacy in treatment-naïve patients with metastatic renal cell carcinoma

Por Harmon, Charles S., DePrimo, Samuel E., Figlin, Robert A., Hudes, Gary R., Hutson, Thomas E., Michaelson, M. Dror, Négrier, Sylvie, Kim, Sindy T., Huang, Xin, Williams, J. Andrew, Eisen, Tim, Motzer, Robert J.
Publicado em 2013

Complete Longitudinal Analyses of the Randomized, Placebo-controlled, Phase III Trial of Sunitinib in Patients with Gastrointestinal Stromal Tumor Following Imatinib Failure

Por Demetri, George D., Garrett, Christopher R., Schöffski, Patrick, Shah, Manisha H., Verweij, Jaap, Leyvraz, Serge, Hurwitz, Herbert I., Pousa, Antonio Lopez, Le Cesne, Axel, Goldstein, David, Paz-Ares, Luis, Blay, Jean-Yves, McArthur, Grant A., Xu, Qiang (Casey), Huang, Xin, Harmon, Charles S., Tassell, Vanessa, Cohen, Darrel P., Casali, Paolo G.
Publicado em 2012